Severity of SARS-Cov-2 infection and angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

File Type:
PDFItem Type:
Journal ArticleDate:
2020Author:
Access:
openAccessCitation:
Oscanoa, T. J., Vidal, X., Carvajal, A., Amado, J., Romero-Ortuno, R., Severity of SARS-Cov-2 infection and angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis, Arterial Hypertension, 2020, 24, 3, 106-114Download Item:

Abstract:
Background: The mechanism of entry of SARS-CoV-2 into the human host cell is through the ACE2 receptor. During the pandemic, a hypothesis has been proposed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) could be risk factors for the development of severe SARS-CoV-2 infection.The objective of the study was to conduct a meta-analysis of the association between ACEI or ARB use and SARS-CoV-2 infection severity or mortality. Data Sources: We searched PubMed, EMBASE, Google scholar and the Cochrane Database of Systematic Reviews for observational studies published between December 2019 and August 4, 2020. Study Selection: Studies were included if they contained data on ACEIor ARB use and SARS-CoV-2 infection severity or mortality. Effect statistics were pooled using random-effects models. The quality of included studies was assessed with the Newcastle–Ottawa Scale (NOS). Data extraction: Data on study design, study location, year of publication, number of participants, sex, age at baseline, outcome definition, exposure definition, effect estimates and 95% CIs. Results: Twenty-six studies (21cohort studies and 5 case-control studies) were identified for inclusion,combining to a total sample of 361467 participants. Mean age was 61.48 (SD8.26) years and 51.63 % were men. The mean NOS score of included studies was 7.85 (range: 7–9). Results suggested that ACEI or ARB use did not increase the risk of severe disease or mortality from SARS-CoV-2 infection (OR=0.88, 95% CI:0.75–1.02, p>0.05). Conclusions: At present, the evidence available does not support the hypothesis of increased SARS-CoV-2 risk with ACEI or ARB drugs.
Author's Homepage:
http://people.tcd.ie/romeroorDescription:
PUBLISHED
Author: Romero-Ortuno, Roman
Other Titles:
Severity of SARS-COV-2 infection and renin–angiotensin system blockers: a metanalysisType of material:
Journal ArticleCollections:
Series/Report no:
Arterial Hypertension;Availability:
Full text availableKeywords:
SARS-CoV-2, COVID-19, Angiotensin II receptor blockers, Angiotensin-converting enzyme inhibitors, Renin–Angiotensin System (RAS)Subject (TCD):
AgeingDOI:
10.5603/AH.a2020.0013Licences:
Related items
Showing items related by title, author, creator and subject.
-
Effect of Angiotensin II and Small GTPase Ras Signaling Pathway Inhibition on Early Renal Changes in a Murine Model of Obstructive Nephropathy
DOCHERTY, NEIL (2014)Tubulointerstitial fibrosis is a major feature of chronic kidney disease. Unilateral ureteral obstruction (UUO) in rodents leads to the development of renal tubulointerstitial fibrosis consistent with histopathological ... -
Lack of association between angiotensin-converting enzyme genotype and muscle strength in Peruvian older people
Romero-Ortuno, Roman; Oscanoa, T.J.; Cieza, E.C.; Lizaraso-Soto, F.A.; Guevara, M.L.; Fujita, R.M.; Parodi, J.F.; Runzer-Colmenares, F.M. (2020)Aging can be associated with decreasing muscle strength, and related factors are comorbidities, sex, physical activity, and possibly genetic factors. Among genetic factors the renin-angiotensin system is of interest, but ... -
Angiotensin-Converting Enzyme (ACE) genetic variation and longevity in Peruvian older people: a cross-sectional study
Romero-Ortuno, Roman; Oscanoa, Teodoro J.; Cieza, Edwin C.; Lizaraso-Soto, Frank A.; Guevara, María L.; Fujita, Ricardo M. (2020)Background: Some studies have suggested that the insertion(I)/deletion(D) polymorphism of the Angiotensin-Converting Enzyme (ACE) gene may be associated with human longevity, especially in centenarians. However, this ...